The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a member of the nuclear receptor superfamily of ligand-dependent transcription factors that is predominantly expressed in adipose tissue, adrenal gland and spleen. PPAR-gamma has been demonstrated to regulate adipocyte differentiation and glucose homeostasis in response to several structurally distinct compounds, including thiazolidinediones and fibrates. Naturally occurring compounds such as fatty acids and the prostaglandin D2 metabolite 15-deoxy-delta prostaglandin J2 (15d-PGJ2) bind to PPAR-gamma and stimulate transcription of target genes. Prostaglandin D2 metabolites have not yet been identified in adipose tissue, but are major products of arachidonic-acid metabolism in macrophages, raising the possibility that they might serve as endogenous PPAR-gamma ligands in this cell type. Here we show that PPAR-gamma is markedly upregulated in activated macrophages and inhibits the expression of the inducible nitric oxide synthase, gelatinase B and scavenger receptor A genes in response to 15d-PGJ2 and synthetic PPAR-gamma ligands. PPAR-gamma inhibits gene expression in part by antagonizing the activities of the transcription factors AP-1, STAT and NF-kappaB. These observations suggest that PPAR-gamma and locally produced prostaglandin D2 metabolites are involved in the regulation of inflammatory responses, and raise the possibility that synthetic PPAR-gamma ligands may be of therapeutic value in human diseases such as atherosclerosis and rheumatoid arthritis in which activated macrophages exert pathogenic effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In microglia and macrophages, PPAR␥ activation inhibits proinflammatory gene expression (Jiang et al., 1998;Ricote et al., 1998).”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Ricote et al., 1998
In the citing paper
“Moreover, inhibiting nuclear factor B (NFB) decreases expression of inflammatory cytokines such as interleukin (IL)-1, tumor necrosis factor ␣ (TNF␣) or IL-6 (12).”
From MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor γ (PPARγ) mRNA Destabilization (2010) · cites this paper as [12]
In the citing paper
“PPAR␥ is well established for its anti-inflammatory effects in attenuating the production of pro-inflammatory mediators (12).”
From MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor γ (PPARγ) mRNA Destabilization (2010) · cites this paper as [12]
In the citing paper
“Next to its role in HSCs, PPAR-γ is primarily expressed in macrophages and is capable to inhibit AP-1, STAT1 and NF-κB, therefore decreasing the inflammatory response.[136]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [136]
In the citing paper
“Next to its role in HSCs, PPAR-γ is primarily expressed in macrophages and is capable to inhibit AP-1, STAT1 and NF-κB, therefore decreasing the inflammatory response.[136]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [136]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,077
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Self-citationStimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Self-citationKliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
The matrix‐degrading metalloproteinases
Matrisian, L. M. (1992) · BioEssays · doi:10.1002/bies.950140705 · Cited by 1,364
Krey, G. D., Braissant, O., L’Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., & Wahli, W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.779 · Cited by 1,221
Cited by
Items 301–400 of 1,039
The Anti-Inflammatory Effects of Prostaglandins
Scher, J. U., & Pillinger, M. H. (2009) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31819aaa76 · Cited by 259
Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation
Castrillo, A., & Tontonoz, P. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.134432 · Cited by 260
Girnun, G. D., Domann, F. E., Moore, S. A., & Robbins, M. E. C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0020 · Cited by 259
Labandeira-Garcia, J. L., Rodríguez-Perez, A. I., Garrido-Gil, P., Rodriguez-Pallares, J., Lanciego, J. L., & Guerra, M. J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00129 · Cited by 249
Marx, N., Froehlich, J., Siam, L., Ittner, J., Wierse, G., Schmidt, A., Scharnagl, H., Hombach, V., & Koenig, W. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000054195.35121.5e · Cited by 257
Rajaram, M. V. S., Brooks, M. N., Morris, J. D., Torrelles, J. B., Azad, A. K., & Schlesinger, L. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000866 · Cited by 245
The Toxicology of Ligands for Peroxisome Proliferator-Activated Receptors (PPAR)
Peraza, M. A., Burdick, A. D., Marin, H. E., Gonzalez, F. J., & Peters, J. M. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj062 · Cited by 254
Shiomi, T., Tsutsui, H., Hayashidani, S., Suematsu, N., Ikeuchi, M., Wen, J., Ishibashi, M., Kubota, T., Egashira, K., & Takeshita, A. (2002) · Circulation · doi:10.1161/01.cir.0000039346.31538.2c · Cited by 255
Knouff, C., & Auwerx, J. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0036 · Cited by 256
A Novel CCCH-Zinc Finger Protein Family Regulates Proinflammatory Activation of Macrophages
Liang, J., Wang, J., Azfer, A., Song, W., Tromp, G., Kolattukudy, P. E., & Fu, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707861200 · Cited by 252
A Nuclear Receptor Atlas: Macrophage Activation
Barish, G. D., Downes, M., Alaynick, W. A., Yu, R. T., Ocampo, C. B., Bookout, A. L., Mangelsdorf, D. J., & Evans, R. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0529 · Cited by 243
PPAR and Oxidative Stress: Con() Catenating NRF2 and FOXO
Polvani, S., Tarocchi, M., & Galli, A. (2012) · PPAR Research · doi:10.1155/2012/641087 · Cited by 245
Asakawa, M., Takano, H., Nagai, T., Uozumi, H., Hasegawa, H., Kubota, N., Saito, T., Masuda, Y., Kadowaki, T., & Komuro, I. (2002) · Circulation · doi:10.1161/hc1002.105225 · Cited by 255
Macrophage Scavenger Receptor Class A: A Multifunctional Receptor in Atherosclerosis
de Winther, M. P. J., van Dijk, K. W., Havekes, L. M., & Hofker, M. H. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.290 · Cited by 249
25-Hydroxycholesterol acts as an amplifier of inflammatory signaling
Gold, E. S., Diercks, A. H., Podolsky, I., Podyminogin, R. L., Askovich, P. S., Treuting, P. M., & Aderem, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404271111 · Cited by 250
Regulation of Lipid and Lipoprotein Metabolism by PPAR Activators
Gervois, P., Torra, I. P., Fruchart, J.-C., & Staels, B. (2000) · cclm · doi:10.1515/cclm.2000.002 · Cited by 249
Obesity and aging: Molecular mechanisms and therapeutic approaches
Santos, A. L., & Sinha, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101268 · Cited by 230
The role of PPARs in atherosclerosis
Duval, C., Chinetti, G., Trottein, F., Fruchart, J.-C., & Staels, B. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02385-7 · Cited by 246
Lipidomic Profiling of Influenza Infection Identifies Mediators that Induce and Resolve Inflammation
Tam, V. C., Quehenberger, O., Oshansky, C. M., Suen, R., Armando, A. M., Treuting, P. M., Thomas, P. G., Dennis, E. A., & Aderem, A. (2013) · Cell · doi:10.1016/j.cell.2013.05.052 · Cited by 245
PGC1β Mediates PPARγ Activation of Osteoclastogenesis and Rosiglitazone-Induced Bone Loss
Wei, W., Wang, X., Yang, M., Smith, L. C., Dechow, P. C., & Wan, Y. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.015 · Cited by 243
Production of Eicosanoids and Other Oxylipins by Pathogenic Eukaryotic Microbes
Noverr, M. C., Erb-Downward, J. R., & Huffnagle, G. B. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.517-533.2003 · Cited by 243
Zhao, X., Zhang, Y., Strong, R., Grotta, J. C., & Aronowski, J. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600233 · Cited by 245
The Regulation of Chondrocyte Function by Proinflammatory Mediators: Prostaglandins and Nitric Oxide
Goldring, M. B., & Berenbaum, F. (2004) · Clinical Orthopaedics & Related Research · doi:10.1097/01.blo.0000144484.69656.e4 · Cited by 245
Woerly, G., Honda, K., Loyens, M., Papin, J.-P., Auwerx, J., Staels, B., Capron, M., & Dombrowicz, D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021384 · Cited by 244
Heme oxygenase and carbon monoxide initiate homeostatic signaling
Bilban, M., Haschemi, A., Wegiel, B., Chin, B. Y., Wagner, O., & Otterbein, L. E. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0276-0 · Cited by 241
Feng, J., Han, J., Pearce, S. F. A., Silverstein, R. L., Gotto, A. M., Hajjar, D. P., & Nicholson, A. C. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32377-4 · Cited by 241
Bento, A. F., Marcon, R., Dutra, R. C., Claudino, R. F., Cola, M., Pereira Leite, D. F., & Calixto, J. B. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.052 · Cited by 224
Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair
Cai, W., Yang, T., Liu, H., Han, L., Zhang, K., Hu, X., Zhang, X., Yin, K.-J., Gao, Y., Bennett, M. V. L., et al. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.002 · Cited by 236
Peroxisome proliferator-activated receptor gamma (PPARγ) and its ligands: A review
Houseknecht, K. L., Cole, B. M., & Steele, P. J. (2002) · Domestic Animal Endocrinology · doi:10.1016/s0739-7240(01)00117-5 · Cited by 232
Vascular endothelial cell Toll-like receptor pathways in sepsis
Khakpour, S., Wilhelmsen, K., & Hellman, J. (2015) · Innate Immunity · doi:10.1177/1753425915606525 · Cited by 234
The roles of TNF in brain dysfunction and disease
Clark, I. A., Alleva, L. M., & Vissel, B. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.007 · Cited by 232
Inoue, H., Jiang, X.-F., Katayama, T., Osada, S., Umesono, K., & Namura, S. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.09.001 · Cited by 232
Regulation of Cytokine Expression by Ligands of Peroxisome Proliferator Activated Receptors
Cunard, R., Ricote, M., DiCampli, D., Archer, D. C., Kahn, D. A., Glass, C. K., & Kelly, C. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2795 · Cited by 238
Self-citationMultiple role of reactive oxygen species in the arterial wall
Napoli, C., de Nigris, F., & Palinski, W. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1198 · Cited by 239
Non-steroidal anti-inflammatory drugs in Parkinson's disease
Esposito, E., Di Matteo, V., Benigno, A., Pierucci, M., Crescimanno, G., & Di Giovanni, G. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.02.008 · Cited by 234
Colville-Nash, P. R., Qureshi, S. S., Willis, D., & Willoughby, D. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.978 · Cited by 241
Wu, M., Melichian, D. S., Chang, E., Warner-Blankenship, M., Ghosh, A. K., & Varga, J. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080574 · Cited by 233
Koliwad, S. K., Streeper, R. S., Monetti, M., Cornelissen, I., Chan, L., Terayama, K., Naylor, S., Rao, M., Hubbard, B., & Farese, R. V. (2010) · Journal of Clinical Investigation · doi:10.1172/jci36066 · Cited by 233
Kleemann, R., Gervois, P. P., Verschuren, L., Staels, B., Princen, H. M. G., & Kooistra, T. (2003) · Blood · doi:10.1182/blood-2002-06-1762 · Cited by 229
The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery
Dutta, G., Zhang, P., & Liu, B. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00616.x · Cited by 235
Convergence of Peroxisome Proliferator-activated Receptor γ and Foxo1 Signaling Pathways
Dowell, P., Otto, T. C., Adi, S., & Lane, M. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309069200 · Cited by 233
Welch, J. S., Escoubet-Lozach, L., Sykes, D. B., Liddiard, K., Greaves, D. R., & Glass, C. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205873200 · Cited by 233
Self-citationThe Macrophage-Osteoclast Axis in Osteoimmunity and Osteo-Related Diseases
Yao, Y., Cai, X., Ren, F., Ye, Y., Wang, F., Zheng, C., Qian, Y., & Zhang, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.664871 · Cited by 224
Nrf2-regulated PPARγ Expression Is Critical to Protection against Acute Lung Injury in Mice
Cho, H.-Y., Gladwell, W., Wang, X., Chorley, B., Bell, D., Reddy, S. P., & Kleeberger, S. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-1047oc · Cited by 226
Insulin resistance and hyperinsulinaemia in the development and progression of cancer
Godsland, I. F. (2010) · Clinical Science · doi:10.1042/cs20090399 · Cited by 231
Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-γActivation
Jacob, A., Wu, R., Zhou, M., & Wang, P. (2007) · PPAR Research · doi:10.1155/2007/89369 · Cited by 228
Healing fats of the skin: the structural and immunologic roles of the ω-6 and ω-3 fatty acids
McCusker, M. M., & Grant-Kels, J. M. (2010) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2010.03.020 · Cited by 227
Increased CD36 protein as a response to defective insulin signaling in macrophages
Liang, C.-P., Han, S., Okamoto, H., Carnemolla, R., Tabas, I., Accili, D., & Tall, A. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19528 · Cited by 225
Higa, M., Zhou, Y.-T., Ravazzola, M., Baetens, D., Orci, L., & Unger, R. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11513 · Cited by 235
Peiser, L., & Gordon, S. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(00)01362-9 · Cited by 225
Torra, I. P., Gervois, P., & Staels, B. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199904000-00009 · Cited by 231
Shu, H., Wong, B., Zhou, G., Li, Y., Berger, J., Woods, J. W., Wright, S. D., & Cai, T.-Q. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1968 · Cited by 229
Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components
Martin, H. (2010) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2009.09.009 · Cited by 227
Komar, C. M. (2005) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-3-41 · Cited by 219
Ghanim, H., Garg, R., Aljada, A., Mohanty, P., Kumbkarni, Y., Assian, E., Hamouda, W., & Dandona, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7309 · Cited by 218
Metabolic control of the Treg/Th17 axis
Barbi, J., Pardoll, D., & Pan, F. (2013) · Immunological Reviews · doi:10.1111/imr.12029 · Cited by 217
Gasparini, L., Ongini, E., & Wenk, G. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02743.x · Cited by 226
Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas
Heaney, A. P., Fernando, M., Yong, W. H., & Melmed, S. (2002) · Nature Medicine · doi:10.1038/nm784 · Cited by 226
Natrajan, M. S., de la Fuente, A. G., Crawford, A. H., Linehan, E., Nuñez, V., Johnson, K. R., Wu, T., Fitzgerald, D. C., Ricote, M., Bielekova, B., et al. (2015) · Brain · doi:10.1093/brain/awv289 · Cited by 218
Self-citationCarson, W. E., Parihar, R., Lindemann, M. J., Personeni, N., Dierksheide, J., Meropol, N. J., Baselga, J., & Caligiuri, M. A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j · Cited by 155
A Paradigm for Gene Regulation: Inflammation, NF-κB and PPAR
Vanden Berghe, W., Vermeulen, L., Delerive, P., De Bosscher, K., Staels, B., & Haegeman, G. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9072-3_22 · Cited by 222
Cyclooxygenases and prostaglandins: shaping up the immune response
Rocca, B., & FitzGerald, G. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00204-1 · Cited by 219
Digby, J. E., Martinez, F., Jefferson, A., Ruparelia, N., Chai, J., Wamil, M., Greaves, D. R., & Choudhury, R. P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241836 · Cited by 221
The pleiotropic functions of peroxisome proliferator-activated receptor γ
Debril, M.-B., Renaud, J.-P., Fajas, L., & Auwerx, J. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090000145 · Cited by 220
Bernardo, A., Levi, G., & Minghetti, L. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00110.x · Cited by 222
Angiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders
Saavedra, J. M. (2012) · Clinical Science · doi:10.1042/cs20120078 · Cited by 217
Jeon, M. J., Kim, J. A., Kwon, S. H., Kim, S. W., Park, K. S., Park, S.-W., Kim, S. Y., & Shin, C. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211610200 · Cited by 214
The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis
Makowski, L., & Hotamisligil, G. S. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000180166.08196.07 · Cited by 219
Chatterjee, P. K. (2007) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-007-0183-5 · Cited by 222
Peroxisome Proliferator-Activated Receptors, Coactivators, and Downstream Targets
Qi, C., Zhu, Y., & Reddy, J. K. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:32:1-3:187 · Cited by 216
Resolution of inflammation: Mechanisms and opportunity for drug development
Alessandri, A. L., Sousa, L. P., Lucas, C. D., Rossi, A. G., Pinho, V., & Teixeira, M. M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.04.006 · Cited by 213
Liang, Y.-C., Tsai, S.-H., Tsai, D.-C., Lin-Shiau, S.-Y., & Lin, J.-K. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02393-6 · Cited by 217
Be Fit or Be Sick: Peroxisome Proliferator-Activated Receptors Are Down the Road
Desvergne, B., Michalik, L., & Wahli, W. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0088 · Cited by 222
PPARs and lipid ligands in inflammation and metabolism
Harmon, G. S., Lam, M. T., & Glass, C. K. (2011) · Chemical Reviews · doi:10.1021/cr2001355 · Cited by 216
Self-citationKIAEI, M., KIPIANI, K., CHEN, J., CALINGASAN, N., & BEAL, M. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.10.007 · Cited by 214
Park, E. J., Park, S. Y., Joe, E.-H., & Jou, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210819200 · Cited by 214
Vunta, H., Davis, F., Palempalli, U. D., Bhat, D., Arner, R. J., Thompson, J. T., Peterson, D. G., Reddy, C. C., & Prabhu, K. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703075200 · Cited by 212
Cuzzocrea, S., Pisano, B., Dugo, L., Ianaro, A., Maffia, P., Patel, N. S. A., Di Paola, R., Ialenti, A., Genovese, T., Chatterjee, P. K., et al. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.10.056 · Cited by 214
RetractedRegulation of Macrophage Inflammatory Gene Expression by the Orphan Nuclear Receptor Nur77
Pei, L., Castrillo, A., & Tontonoz, P. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0331 · Cited by 206
Receptors for oxidized low density lipoprotein
Steinbrecher, U. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s0005-2760(98)00127-1 · Cited by 211
Lee, T.-S., Tsai, H.-L., & Chau, L.-Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300498200 · Cited by 211
The Potential Contributions of Chronic Inflammation to Lung Carcinogenesis
Ballaz, S., & Mulshine, J. L. (2003) · Clinical Lung Cancer · doi:10.3816/clc.2003.n.021 · Cited by 212
Greaves, D. R., & Gordon, S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r400011-jlr200 · Cited by 211
Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis
Neve, B. P., Fruchart, J.-C., & Staels, B. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00430-5 · Cited by 211
Adachi, M., Kurotani, R., Morimura, K., Shah, Y., Sanford, M., Madison, B. B., Gumucio, D. L., Marin, H. E., Peters, J. M., Young, H. A., et al. (2006) · Gut · doi:10.1136/gut.2005.081745 · Cited by 209
Kalra, S., Malik, R., Singh, G., Bhatia, S., Al-Harrasi, A., Mohan, S., Albratty, M., Albarrati, A., & Tambuwala, M. M. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01017-8 · Cited by 193
Wang, N., Verna, L., Chen, N.-G., Chen, J., Li, H., Forman, B. M., & Stemerman, M. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203436200 · Cited by 208
PPARs and the Cardiovascular System
Hamblin, M., Chang, L., Fan, Y., Zhang, J., & Chen, Y. E. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2280 · Cited by 207
Natarajan, C., & Bright, J. J. (2002) · Genes & Immunity · doi:10.1038/sj.gene.6363832 · Cited by 208
Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis†
Maher, J. J., Leon, P., & Ryan, J. C. (2008) · Hepatology · doi:10.1002/hep.22399 · Cited by 203
Ellis, C. N., Varani, J., Fisher, G. J., Zeigler, M. E., Pershadsingh, H. A., Benson, S. C., Chi, Y., & Kurtz, T. W. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.5.609 · Cited by 212
Kitamura, Y., Shimohama, S., Koike, H., Kakimura, J.-I., Matsuoka, Y., Nomura, Y., Gebicke-Haerter, P. J., & Taniguchi, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9981 · Cited by 207
Composition and Potential Health Benefits of Pomegranate: A Review
Vučić, V., Grabež, M., Trchounian, A., & Arsić, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190708183941 · Cited by 192
Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage
YI, J., PARK, S., KAPADIA, R., & VEMUGANTI, R. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.04.019 · Cited by 206
Luo, Y., Yin, W., Signore, A. P., Zhang, F., Hong, Z., Wang, S., Graham, S. H., & Chen, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03758.x · Cited by 203
BENAYOUN, L., LETUVE, S., DRUILHE, A., BOCZKOWSKI, J., DOMBRET, M.-C., MECHIGHEL, P., MEGRET, J., LESECHE, G., AUBIER, M., & PRETOLANI, M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.8.2101070 · Cited by 204
Beneficial effects of PPAR-? ligands in ischemia?reperfusion injury, inflammation and shock
ABDELRAHMAN, M., SIVARAJAH, A., & THIEMERMANN, C. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.008 · Cited by 205
Peroxisome Proliferator-Activated Receptor α Agonists as Therapy for Autoimmune Disease
Lovett-Racke, A. E., Hussain, R. Z., Northrop, S., Choy, J., Rocchini, A., Matthes, L., Chavis, J. A., Diab, A., Drew, P. D., & Racke, M. K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5790 · Cited by 207
Fatty Acids and Immune Responses—A New Perspective in Searching for Clues to Mechanism
Hwang, D. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.431 · Cited by 205
Russo, E., Giudici, F., Fiorindi, C., Ficari, F., Scaringi, S., & Amedei, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02754 · Cited by 204
Metadata
- Authors
- Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K.
- Affiliations
- United States Department of Veterans Affairs (US)
- Veterans Health Administration (US)
- University of California San Diego (US)
- Corresponding author
- Glass, Christopher K.
- Venue
- Nature
- Published
- 1998-01
- Volume
- 391
- Issue
- 6662
- Pages
- 79-82
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1633340712
- Cited by
- 3,525
- References
- 27
- Citations by year
- 2026: 30 · 2025: 41 · 2024: 34 · 2023: 44 · 2022: 59 · 2021: 84 · 2020: 73 · 2019: 65 · 2018: 89 · 2017: 82 · 2016: 86 · 2015: 95 · 2014: 113 · 2013: 106 · 2012: 137
- FWCI
- 53.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- PPARγ, macrophage activation, prostaglandin D2 metabolites, inducible nitric oxide synthase, MMP-9, scavenger receptor A, AP-1, STAT, NF-κB, transcriptional regulation, inflammation, atherosclerosis, rheumatoid arthritis, PPARγ ligands
- MeSH terms
- Bone Marrow Cells, Gene Expression Regulation, HeLa Cells, Humans, Macrophage Activation, Macrophages, Promoter Regions, Genetic, Transcription Factors, Tumor Cells, Cultured, Prostaglandin D2, Collagenases, Macrophages, Peritoneal, Receptors, Cytoplasmic and Nuclear, Inflammation Mediators, Nitric Oxide Synthase, Matrix Metalloproteinase 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.